Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

NCT00017680 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Amyloidosis

Interventions

DRUG: Melphalan
PROCEDURE: Autologous Stem Cell Transplantation

Sponsor

Herbert Irving Comprehensive Cancer Center